Matches in SemOpenAlex for { <https://semopenalex.org/work/W2515738749> ?p ?o ?g. }
- W2515738749 endingPage "660" @default.
- W2515738749 startingPage "649" @default.
- W2515738749 abstract "Prophylactic paracetamol administration impacts vaccine immune response; this study (www.clinicaltrials.gov: NCT01235949) is the first to assess PHiD-CV immunogenicity following prophylactic ibuprofen administration. In this phase IV, multicenter, open-label, randomized, controlled, non-inferiority study in Romania (November 2010–December 2012), healthy infants were randomized 3:3:3:1:1:1 to prophylactically receive immediate, delayed or no ibuprofen (IIBU, DIBU, NIBU) or paracetamol (IPARA, DPARA, NPARA) after each of 3 primary doses (PHiD-CV at age 3/4/5 months co-administered with DTPa-HBV-IPV/Hib at 3/5 and DTPa-IPV/Hib at 4 months) or booster dose (PHiD-CV and DTPa-HBV-IPV/Hib; 12–15 months). Non-inferiority of immune response one month post-primary vaccination in terms of percentage of infants with anti-pneumococcal antibody concentrations ≥0.2 µg/mL (primary objective) was demonstrated if the upper limit (UL) of the 98.25% confidence interval of difference between groups (NIBU vs IIBU, NIBU vs DIBU) was <10% for ≥7/10 serotypes. Immunogenicity and reactogenicity/safety were evaluated, including confirmatory analysis of difference in fever incidences post-primary vaccination in IBU or DIBU group compared to NIBU. Of 850 infants randomized, 812 were included in the total vaccinated cohort. Non-inferiority was demonstrated for both comparisons (UL was <10% for 9/10 vaccine serotypes; exceptions: 6B [NIBU], 23F [IIBU]). However, fever incidence post-primary vaccination in the IIBU and DIBU groups did not indicate a statistically significant reduction. Prophylactic administration (immediate or delayed) of paracetamol decreased fever incidence but seemed to reduce immune response to PHiD-CV, except when given only at booster. Twenty-seven serious adverse events were reported for 15 children; all resolved and were not vaccination-related." @default.
- W2515738749 created "2016-09-16" @default.
- W2515738749 creator A5004634899 @default.
- W2515738749 creator A5013099685 @default.
- W2515738749 creator A5013245992 @default.
- W2515738749 creator A5030216401 @default.
- W2515738749 creator A5034325843 @default.
- W2515738749 creator A5044909063 @default.
- W2515738749 creator A5046909895 @default.
- W2515738749 creator A5047610636 @default.
- W2515738749 creator A5049664874 @default.
- W2515738749 creator A5050384218 @default.
- W2515738749 creator A5061114784 @default.
- W2515738749 creator A5068631217 @default.
- W2515738749 creator A5078658205 @default.
- W2515738749 creator A5087933932 @default.
- W2515738749 creator A5090071127 @default.
- W2515738749 creator A5091323542 @default.
- W2515738749 date "2016-08-19" @default.
- W2515738749 modified "2023-09-30" @default.
- W2515738749 title "Effects of prophylactic ibuprofen and paracetamol administration on the immunogenicity and reactogenicity of the 10-valent pneumococcal non-typeable<i>Haemophilus influenzae</i>protein D conjugated vaccine (PHiD-CV) co-administered with DTPa-combined vaccines in children: An open-label, randomized, controlled, non-inferiority trial" @default.
- W2515738749 cites W1594707968 @default.
- W2515738749 cites W160449951 @default.
- W2515738749 cites W1933165630 @default.
- W2515738749 cites W1943307706 @default.
- W2515738749 cites W1969303209 @default.
- W2515738749 cites W1978248470 @default.
- W2515738749 cites W1991262879 @default.
- W2515738749 cites W2000897683 @default.
- W2515738749 cites W2002537875 @default.
- W2515738749 cites W2007644270 @default.
- W2515738749 cites W2034683735 @default.
- W2515738749 cites W2044704048 @default.
- W2515738749 cites W2051453885 @default.
- W2515738749 cites W2053304919 @default.
- W2515738749 cites W2058305495 @default.
- W2515738749 cites W2067885622 @default.
- W2515738749 cites W2074074587 @default.
- W2515738749 cites W2081829752 @default.
- W2515738749 cites W2099607051 @default.
- W2515738749 cites W2112594505 @default.
- W2515738749 cites W2117774985 @default.
- W2515738749 cites W2118054413 @default.
- W2515738749 cites W2125089365 @default.
- W2515738749 cites W2127699766 @default.
- W2515738749 cites W2146477509 @default.
- W2515738749 cites W2149679517 @default.
- W2515738749 cites W2151165850 @default.
- W2515738749 cites W2155601189 @default.
- W2515738749 cites W2158965885 @default.
- W2515738749 cites W2419296990 @default.
- W2515738749 cites W2952085197 @default.
- W2515738749 cites W4248548485 @default.
- W2515738749 doi "https://doi.org/10.1080/21645515.2016.1223001" @default.
- W2515738749 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5360152" @default.
- W2515738749 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27541270" @default.
- W2515738749 hasPublicationYear "2016" @default.
- W2515738749 type Work @default.
- W2515738749 sameAs 2515738749 @default.
- W2515738749 citedByCount "18" @default.
- W2515738749 countsByYear W25157387492017 @default.
- W2515738749 countsByYear W25157387492018 @default.
- W2515738749 countsByYear W25157387492019 @default.
- W2515738749 countsByYear W25157387492020 @default.
- W2515738749 countsByYear W25157387492021 @default.
- W2515738749 countsByYear W25157387492022 @default.
- W2515738749 countsByYear W25157387492023 @default.
- W2515738749 crossrefType "journal-article" @default.
- W2515738749 hasAuthorship W2515738749A5004634899 @default.
- W2515738749 hasAuthorship W2515738749A5013099685 @default.
- W2515738749 hasAuthorship W2515738749A5013245992 @default.
- W2515738749 hasAuthorship W2515738749A5030216401 @default.
- W2515738749 hasAuthorship W2515738749A5034325843 @default.
- W2515738749 hasAuthorship W2515738749A5044909063 @default.
- W2515738749 hasAuthorship W2515738749A5046909895 @default.
- W2515738749 hasAuthorship W2515738749A5047610636 @default.
- W2515738749 hasAuthorship W2515738749A5049664874 @default.
- W2515738749 hasAuthorship W2515738749A5050384218 @default.
- W2515738749 hasAuthorship W2515738749A5061114784 @default.
- W2515738749 hasAuthorship W2515738749A5068631217 @default.
- W2515738749 hasAuthorship W2515738749A5078658205 @default.
- W2515738749 hasAuthorship W2515738749A5087933932 @default.
- W2515738749 hasAuthorship W2515738749A5090071127 @default.
- W2515738749 hasAuthorship W2515738749A5091323542 @default.
- W2515738749 hasBestOaLocation W25157387491 @default.
- W2515738749 hasConcept C120665830 @default.
- W2515738749 hasConcept C121332964 @default.
- W2515738749 hasConcept C126322002 @default.
- W2515738749 hasConcept C159654299 @default.
- W2515738749 hasConcept C168563851 @default.
- W2515738749 hasConcept C187212893 @default.
- W2515738749 hasConcept C203014093 @default.
- W2515738749 hasConcept C22070199 @default.
- W2515738749 hasConcept C2776925733 @default.
- W2515738749 hasConcept C2777704310 @default.
- W2515738749 hasConcept C2778715236 @default.
- W2515738749 hasConcept C2780868878 @default.
- W2515738749 hasConcept C501593827 @default.